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Abstract
Background: Critical to advancing the systems-level evaluation of complex biological processes is the
development of comprehensive networks and computational methods to apply to the analysis of systems biology
data (transcriptomics, proteomics/phosphoproteomics, metabolomics, etc.). Ideally, these networks will be
specifically designed to capture the normal, non-diseased biology of the tissue or cell types under investigation,
and can be used with experimentally generated systems biology data to assess the biological impact of
perturbations like xenobiotics and other cellular stresses. Lung cell proliferation is a key biological process to
capture in such a network model, given the pivotal role that proliferation plays in lung diseases including cancer,
chronic obstructive pulmonary disease (COPD), and fibrosis. Unfortunately, no such network has been available
prior to this work.
Results: To further a systems-level assessment of the biological impact of perturbations on non-diseased
mammalian lung cells, we constructed a lung-focused network for cell proliferation. The network encompasses
diverse biological areas that lead to the regulation of normal lung cell proliferation (Cell Cycle, Growth Factors, Cell
Interaction, Intra- and Extracellular Signaling, and Epigenetics), and contains a total of 848 nodes (biological
entities) and 1597 edges (relationships between biological entities). The network was verified using four published
gene expression profiling data sets associated with measured cell proliferation endpoints in lung and lung-related
cell types. Predicted changes in the activity of core machinery involved in cell cycle regulation (RB1, CDKN1A, and
MYC/MYCN) are statistically supported across multiple data sets, underscoring the general applicability of this
approach for a network-wide biological impact assessment using systems biology data.
Conclusions: To the best of our knowledge, this lung-focused Cell Proliferation Network provides the most
comprehensive connectivity map in existence of the molecular mechanisms regulating cell proliferation in the
lung. The network is based on fully referenced causal relationships obtained from extensive evaluation of the
literature. The computable structure of the network enables its application to the qualitative and quantitative
evaluation of cell proliferation using systems biology data sets. The network is available for public use.
Background
The immediate goal of this work was to construct a
computable network model for cell proliferation in non-
diseased lung. Lung epithelial cells are stimulated to
proliferate upon injury as a mechanism for renewal [1].
Alterations in the control of cell proliferation play a
pivotal role in lung diseases including cancer, COPD,
and pulmonary fibrosis. Cancer results from both gains
of inappropriate growth signaling as well as the loss of
mechanisms inhibiting proliferation [2]. Hyperplasia of
mucus-producing goblet cells and airway smooth muscle
contribute to COPD pathology [3]. Pulmonary fibrosis is
characterized by excessive proliferation of lung fibro-
blasts, resulting in impaired lung function [4]. Thus,
increasing the molecular understanding of the regulation
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any medium, provided the original work is properly cited.of cell proliferation in the lung will serve to aid in the
treatment and prevention of several lung diseases.
Comprehensive and detailed pathway or network
models of the processes that contribute to lung disease
pathology are needed to effectively interpret modern
“omics” data and to qualitatively and quantitatively com-
pare signaling across diverse data sets. The ultimate goal
of this work is to evaluate the biological impact of xeno-
biotics and environmental toxins on experimental sys-
tems such as lung cell cultures or whole rodent lung.
Network models representing key biological processes as
they occur in non-diseased cells are crucial for this
effort. Tumor cell lines and other cell contexts repre-
senting advanced disease states have genetic changes
and altered signaling networks that may not be present
in normal, non-diseased cells. Thus, the network model
d e s c r i b e di nt h i sr e p o r ti sf o c used on biological signal-
ing pathways expected to be functional and to regulate
cell proliferation in non-diseased lung.
Many different approaches can be taken to develop
biological models. Biological pathways such as those
captured by KEGG (Kyoto Encyclopedia of Genes and
Genomes) [5] are manually drawn pathway maps linking
genes to pathways; KEGG pathways have limited com-
putational value for analysis of systems biology data sets
beyond directly mapping observed changes to pathways
and assessing over-representation. Dynamic biochemical
models, such as those commonly encoded in SBML
(systems biology markup language) [6], are useful for
assessing the dynamic behavior of biochemical systems.
However, because dynamic biochemical models require
a large number of parameters, they are generally limited
to representation of simplified and well-constrained bio-
logical processes, and are thus not well suited to the
comprehensive evaluation of complex systems consisting
of multiple inter-related signaling processes.
Reverse Causal Reasoning (RCR) is a systems biology
methodology that evaluates the statistical merit that a
biological entity is active in a given system, based on
automated reasoning to extrapolate back from observed
biological data to plausible explanations for its cause.
RCR requires an extensive Knowledgebase of biological
cause and effect relationships as a substrate. RCR has
been successfully applied to identify and evaluate mole-
cular mechanisms involved in diverse biological pro-
cesses, including hypoxia-induced hemangiosarcoma,
Sirtuin 1-induced keratinocyte differentiation, and
tumor sensitivity to AKT inhibition [7-9]. These pre-
viously published applications of RCR to experimental
data have involved the analysis of diseased states. Here,
we apply RCR to evaluate the biological process of cell
proliferation in normal, non-diseased pulmonary cells.
The lung-focused Cell Proliferation Network described
in this paper was constructed and evaluated by applying
RCR to published gene expression profiling data sets
associated with measured cell proliferation endpoints in
lung and related cell types.
The Cell Proliferation Network reported here provides
a detailed description of molecular processes leading to
cell proliferation in the lung based on causal relation-
ships obtained from extensive evaluation of the litera-
ture. This novel pathway model is comprehensive and
integrates core cell cycle machinery with other signaling
pathways which control cell proliferation in the lung,
including EGF signaling, circadian clock, and Hedgehog.
This pathway model is computable, and can be used for
the qualitative systems-level evaluation of the complex
biological processes contributing to cell proliferation
pathway signaling from experimental gene expression
profiling data. Construction of additional pathway mod-
els for key lung disease processes such as inflammatory
signaling and response to oxidative stress is planned in
order to build a comprehensive network of pathway
models of lung biology relevant to lung disease. Scoring
algorithms are under development to enable application
of this Cell Proliferation Network and other pathway
models to the quantitative evaluation of biological
impact across data sets for different lung diseases, time
points, or environmental perturbations.
Results and Discussion
Cell Proliferation Network construction overview
The construction of the Cell Proliferation Network was
an iterative process, summarized in Figure 1. The selec-
tion of biological boundaries of the model was guided
by literature investigation of signaling pathways relevant
to cell proliferation in the lung. Causal relationships
describing cell proliferation (Additional file 1) were
added to the network model from the Selventa Knowl-
edgebase (a unified collection of over 1.5 million ele-
ments of biological knowledge captured from the public
literature and other sources), with those relationships
coming from lung or lung-relevant cell types prioritized
(see Network boundaries, assumptions, & structure). To
avoid unintentional circularity, we excluded the causal
information from the specific evaluation data sets used
in this study when building and evaluating the network.
These data sets were analyzed using Reverse Causal Rea-
soning (RCR), a method for identifying predictions of
the activity states of biological entities (nodes) that are
statistically significant and consistent with the measure-
ments taken for a given high-throughput data set (see
Materials and Methods for additional detail). The RCR
prediction of literature model nodes in directions con-
sistent with the observations of cell proliferation in the
experiments used to generate the gene expression data
verified that the model is competent to capture mechan-
isms regulating proliferation. Additionally, proliferation-
Westra et al. BMC Systems Biology 2011, 5:105
http://www.biomedcentral.com/1752-0509/5/105
Page 2 of 16relevant nodes predicted by RCR which were not already
represented in the literature model were used to extend
the model. Using this approach, we generated a more
comprehensive network with nodes derived from exist-
ing literature, as well as nodes derived from cell prolif-
eration data sets, to create an integrated Cell
Proliferation Network (see Network Verification and
Expansion).
Cell Proliferation Network content
The Cell Proliferation Network represents a broad col-
lection of biological mechanisms that regulate cell pro-
liferation in the lung, and was built using a framework
that is amenable to computational analyses. The Cell
Proliferation Network (diagrammed in its entirety in
Figure 2 and detailed in Figure 3) contains 848 nodes,
1597 edges (1091 causal edges and 506 non-causal edges
(Table 1)), and was constructed using information from
429 unique PubMed-abstracted literature sources (Addi-
tional file 1). Nodes in the network are biological
entities, such as the mRNA, protein, or enzymatic activ-
ity linked to a given gene; nodes may also be cellular
processes such as “cell proliferation” or phases of the
cell cycle. This fine-grained representation of biological
entities allows for highly accurate qualitative modeling
of biological mechanisms. An example can be seen from
the sub-network detail in Figure 3, showing several
representative network node types, including root pro-
tein nodes (CCNE1), modified protein nodes (RB1 phos-
phorylated at specific serine residues, represented as
RB1 P@X, where X is a specific amino acid residue)
and activity nodes (kinase activity of CDK2 (kaof
(CDK2)) and transcriptional activity of RB1 (taof(RB1)).
Figure 4 contains a key relating the prefixes (for exam-
ple “kaof”) shown in the sub-network detail to their bio-
logical meaning/interpretation. Edges are relationships
between nodes and may be either non-causal or causal.
Non-causal edges connect different forms of a biological
entity, such as an mRNA or protein complex, to its
base protein(s) (for example, STAT6 phosphorylated at
Figure 1 Schematic diagram showing the iterative workflow used to create the Cell Proliferation Network. The Cell Proliferation Network
contains two components. The Literature Model (purple cylinder) was constructed from causal connections (within the tissue context and
biological mechanism model boundaries) from the Selventa Knowledgebase. The content of the Literature Model was verified by performing
Reverse Causal Reasoning (RCR) on four publicly available proliferation relevant data sets. In addition, the Literature Model was augmented with
additional proliferation relevant RCR-derived nodes in this analysis, creating the Integrated Model. The Cell Proliferation Network (red cylinder)
resulted from a comprehensive review of the Integrated Model.
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protein node, STAT6) without an implied causal rela-
tionship. Causal edges are cause-effect relationships
between biological entities, for example the increased
kinase activity of CDK2 causally increases phosphoryla-
tion of RB1 at serine 373. Each causal edge is supported
by a text line of evidence from a specific source refer-
ence. Additional contextual details of the relationship,
such as the species and tissue/cell type in which the
relationship was experimentally identified, are associated
with causal edges. For this work, we used causal edges
derived only from published experiments performed in
human, mouse, and rat model systems, both in vitro
and in vivo. This lung-focused, fully referenced Cell
Proliferation Network provides the most comprehensive
publicly available connectivity map of the molecular
mechanisms regulating proliferative processes in the
lung.
Network boundaries, assumptions, and structure
When constructing the model using content derived
from the Selventa Knowledgebase, some initial boundary
conditions and a priori assumptions relating to tissue
context and biological content were established to con-
strain the substance of the model to its most salient
details.
Tissue context boundaries
Our goal was to build a network model that captures
the biological mechanisms controlling cell proliferation
in non-diseased mammalian lung. To maintain the focus
of the network on these elements, we determined and
applied a set of rules for selecting network content. Ide-
ally, all causal relationships comprising the network
would be supported by published data from experiments
conducted in non-diseased human, mouse, or rat whole
lung. Thus, causal relationships with literature support
Figure 2 The Cell Proliferation Network. A graphical view of the entire Cell Proliferation Network, containing 848 nodes (orange rectangles)
and 1597 edges (grey and black lines interconnecting nodes).
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bronchial epithelial cells, alveolar type II cells, etc.) were
prioritized. However, in many cases, the results of the
relevant detailed experiments have not been published.
Thus, as a second priority, relationships derived from
cell types that are found in the normal lung (fibroblasts,
epithelial/endothelial cells), but not explicitly from lung
were used. The network was focused on relationships
derived from experiments done in human systems,
though relationships from mouse and rat were also
included. Canonical mechanisms, such as the regulation
of E2F transcription factor family members by the reti-
noblastoma protein RB1, were included in the network
even if literature support explicitly demonstrating the
presence of the mechanism in lung-related cells was not
identified. It was assumed that the individual relation-
ships within canonical mechanisms (for example
CDKN1A inhibiting the kinase activity of CDK2) can
occur in the lung. However, if canonical relationships
with specific lung contexts were found in the literature,
they were used. If needed for completing critical
mechanisms within the network, relationships with
other tissue contexts were used, provided they reflected
proliferative processes that can occur in the normal
lung. Causal relationships derived from embryonic tissue
contexts were included, as the embryonic lung repre-
sents a model for non-diseased lung cell proliferation
[10,11]. As a general rule, the use of causal relationships
with tissue contexts from immortalized cell lines was
limited to providing the molecular details for mechan-
isms in the network when these specific relationships
were not available from normal cells; immortalized cell
lines are highly amenable to experimental manipulation
and are thus a valuable system for identifying signaling
pathway details that are most likely conserved in normal
cells. Relationships with tissue contexts derived from
tumors or other diseased tissues were used sparingly in
order to focus the content of the network to the path-
ways involved in normal lung cell proliferation.
Biological mechanism boundaries
The Cell Proliferation Network represents the biological
mechanisms leading to cell proliferation in a specific
organ, the lung. Thus, biological boundaries were
designed to focus the network on the cellular processes
Figure 3 Detail of a sub-network of the Cell Proliferation
Network showing regulation and downstream effects of CDK2
kinase activity. Nodes in the Cell Proliferation Network are
represented by orange rectangles (e.g. CCNE1 or kaof(CDK2) (kinase
activity of CDK2)). Edges on the model (connections between
nodes) are represented as lines. Non-causal edges (e.g. the
relationship between CDK2 and the kaof(CDK2)) are shown in light
grey lines. Causal edges are represented by dark black lines, with
edges ending in arrowheads designating positive relationships (e.g.
increases or activates) and edges ending in a ball designating
negative relationships (e.g. decreases or inhibits). Specific
phosphorylation sites are designated with the P@X representation,
where X is a specific amino acid residue or residue class. For
example, the kinase activity of CDK2 phosphorylates RB1 at serine
(S) residue 373. In the sub-network detail, the “kaof” prefix refers to
the kinase activity of a node, while the “taof” prefix refers to the
transcriptional activity of a node. Figure 4 contains a key relating
the prefixes shown in the sub-network detail to their biological
meaning/interpretation.
Table 1 Cell Proliferation Network statistics
Nodes 848
mRNAs 80
Proteins 299
Phosphoproteins 110
Activities 214
Complexes 67
Protein families 34
Biological processes 16
Proxies 15
Other 13
Total Edges 1597
Causal Edges 1091
Unique PMIDs 429
Summary of relevant statistics describing the content of the Cell Proliferation
Network
Figure 4 Genstruct Technology Platform key for heatmaps. This
schedule explains the symbols and color codes used in Figures 6, 7,
and 8
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ing lung cell proliferation, with a particular emphasis on
the proximal connections to core cell cycle machinery.
Following an exhaustive search of the literature, a set of
pathways were selected for inclusion, while other path-
ways with less direct relevance for proliferation were
excluded, creating the mechanistic biological boundaries
of the network. These biological mechanism boundaries
were used to ensure that the Cell Proliferation Network
represented the most relevant proliferative mechanisms
that occur in the non-diseased lung.
Cell proliferation can be directly or indirectly influ-
enced by a wide range of factors, including external bio-
logical stimuli (e.g. growth factors) and internal
metabolic alterations (e.g. ATP homeostasis). The broad
range of factors that can influence cell proliferation,
coupled with the observation that many proteins
involved in regulating cell proliferation have varying
degrees of biological promiscuity (e.g. p53 also regulates
the DNA damage response and apoptosis [12,13]),
necessitated some additional delineations framing the
biological boundaries of the network. Therefore, in addi-
tion to defining the biological content included in the
network, certain processes and pathways were explicitly
excluded. Specifically, inflammatory cytokine signaling,
the p53-dependent DNA damage response, and path-
ways regulating the induction of/escape from apoptosis
were not included in the network. Finally, components
of the core replication, transcription, and translation
machinery (DNA/RNA polymerases, ribosomes, etc.)
were considered outside the boundaries of the network.
The Cell Proliferation Network was constructed in a
modular fashion using a “building block” framework in
which a core Cell Cycle building block is connected to
additional biological pathways that contribute to cell
proliferation in the lung (Figure 5). These supporting
blocks are peripheral to, but connected to the core cell
cycle machinery regulating proliferative processes in the
lung. Briefly, the five building blocks are:
Cell Cycle
Includes canonical elements of the core machinery regu-
lating entry and exit from the mammalian cell cycle,
including but not limited to cyclin, CDK, and E2F family
members.
Growth Factors
Includes common extracellular growth factors involved
in regulating lung cell proliferation, namely EGF, TGF-
beta, VEGF, and FGF family members. The EGF family
members EGF and TGF-alpha play critical roles in regu-
lating the proliferation of airway epithelial cells through
EGF receptor activation [14,15]. FGF7 and FGF10, lar-
gely through activation of FGFR2-IIIb signaling, stimu-
late lung epithelial cell proliferation as well as regulate
branching morphogenesis in the developing lung
[16,17]. VEGF, a key regulator of normal angiogenesis
and involved in regulating proliferation of human fetal
airway epithelial cells, [18] was also included.
Intra- and Extracellular (IC/EC) Signaling
This block contains diverse elements of the common
intra- and extracellular pathways involved in mediating
lung cell proliferation, including the Hedgehog, Wnt,
and Notch signaling pathways. Hedgehog signaling regu-
lates cell proliferation and branching morphogenesis in
the developing mammalian lung [19,20]. Similarly,
Notch signaling controls lung cell proliferation as well
as differentiation [21]. Elements of the Wnt signaling
pathway are important for mediating the proliferative
processes seen following lung injury [1]. The remaining
areas covered by this building block are calcium signal-
ing, MAPK, Hox, JAK/STAT, mTOR, prostaglandin E2
(PGE2), Clock, and nuclear receptor signaling as rele-
vant to lung cell proliferation.
Cell Interaction
Includes the signal transduction pathways leading to cell
proliferation that originate from the interactions of com-
mon cell adhesion molecules (including ITGB1 com-
plexes with ITGA1-3 chains) and extracellular matrix
components (specifically collagen, fibronectin, and
laminin).
Epigenetics
Includes the main known epigenetic modulators of lung
cell proliferation including the histone deacetylase
(HDAC) family and DNA methyltransferase (DMT)
family member DNMT1. For this block, connections
from these epigenetic mediators to the core cell cycle
components (e.g. CCND1, CDKN2A) were prioritized.
Figure 5 Schematic overview of the “building block”
framework used to construct the network. Five “building blocks”,
each representing areas of biology known to be important for
regulating lung cell proliferation, were used as a conceptual guide
to construct the network. The Cell Cycle, containing the signaling
elements most proximal to driving entry/exit from a proliferative
state, was the central block, while connections from four other
peripheral building blocks (Growth Factors, Cell Interaction,
Epigenetics and Intra- and Extracellular (IC/EC) Signaling) to the Cell
Cycle block were also used to construct the network. Due to the
size and complexity of the IC/EC block, it was further divided into
11 sub-networks, each focused on a distinct area of cellular
signaling related to regulating lung cell proliferation.
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Selection of published cell proliferation transcriptomic data
sets for verification
In order to verify the content of the network, we used
publicly available data from experiments in which cell
proliferation was modulated in the lung or lung relevant
cell types. Specifically, we analyzed transcriptomic data
sets using Reverse Causal Reasoning (RCR), which iden-
tifies upstream controllers ("hypotheses”) that can
explain the significant mRNA State Changes in a given
transcriptomic data set. Upon completing the literature
model, a search was initiated for transcriptomic data
sets to verify and expand the model using public data
repositories such as GEO (Gene Expression Omnibus)
and ArrayExpress. The ideal data set would have been
collected from either whole lung or a specific untrans-
formed lung cell type, involves a simple perturbation
affecting cell proliferation (but only minimally affecting
biological processes outside of proliferation such as
apoptosis), have cell proliferation phenotypic endpoint
data (e.g. cell proliferation assays, or immunostaining
for markers of cell proliferation), and have raw data
available with at least three biological replicates for each
sample group to clearly identify statistically significant
changes in gene expression. Although this ideal data set
w a sn o tf o u n d ,t h e s ec r i t e r i aw e r eu s e dt oi d e n t i f yf o u r
“next best” data sets for these purposes (Table 2). The
EIF4G1 data set (GSE11011) examines gene expression
changes associated with decreased cell proliferation
resulting from EIF4G1 knockdown in human breast
epithelial cells (MCF10A cell line) [22]. The RhoA data
set (GSE5913) examines gene expression changes asso-
ciated with increased cell proliferation in NIH3T3
mouse fibroblasts, caused by the introduction of the
dominant activating RhoA Q63L mutation [23]. The
CTNNB1 data set (PMID 15186480) examines gene
expression changes resulting from expression of consti-
tutively active Ctnnb1-Lef1 fusion protein in embryonic
lung, which causes increased cell proliferation and
altered cell differentiation [24]. Finally, the NR3C1 data
set (E-MEXP-861) examines gene expression changes
resulting from glucocorticoid receptor (GR or NR3C1)
knockout in embryonic mouse lung, which leads to
increased cell proliferation [25]. The EIF4G1 and RhoA
experiments were not performed in lung-derived cells
(they were done in breast epithelial and fibroblast cell
lines, respectively), however were used in the network
construction process due to 1) the proximity of the per-
turbation used to modulate cell proliferation to the
mechanisms which are known to occur in lung cells and
2) the knowledge that these cell types (epithelial cells
and fibroblasts) can be found in the normal lung. By
this reasoning, even though the gene expression studies
in the EIF4G1 and RhoA data sets were not performed
in lung cells directly, we expected to observe the shared
or common mechanisms regulating proliferation in the
cell types commonly found in lung tissue.
Reverse Causal Reasoning on transcriptomic data sets
identifies proliferative mechanisms and verifies the
literature model
We performed RCR analysis on each of these four cell
proliferation transcriptomic data sets and evaluated the
resulting hypotheses. Foremost, we assessed whether
nodes in the cell proliferation literature model were pre-
dicted as hypotheses in directions consistent with their
biological roles (e.g. was the transcriptional activity of
E2F1, a known transcriptional activator of genes
required for cell cycle progression [26], predicted
increased in data sets where cell proliferation was
observed increased?). This analysis served as a means to
verify the content of the literature model, as hypothesis
predictions for a literature node can be taken as evi-
dence that the particular proliferation-relevant mechan-
ism(s) are operating in the context of known
experimentally modulated cell proliferation. Figure 4
Table 2 Data sets analyzed for verification and expansion of the cell proliferation literature model
Data Set EIF4G1 RhoA CTNNB1 NR3C1
Data Set ID GSE11011 GSE5913 PMID15186480 E-MEXP-861
PubMed ID 18426977 17213802 15186480 17901120
Perturbation EIF4G1 siRNA RhoA Q63L constitutive beta-
catenin-LEF-1
glucocorticoid receptor null
Control Samples 3 control 8 control 3 control 3 control
Experimental
Samples
3 siRNA 7 transfected 3 transgenic 3 null
Microarray
Platform
Affymetrix Human Genome
U133A 2.0
Affymetrix Mouse Genome
U74A v2
Affymetrix Mouse
Genome 430A
GE Healthcare CodeLink Mouse Whole
Genome Bioarray
Tissue MCF10A cells NIH3T3 cells day 18.5 embryonic lung day 18.5 embryonic lung
Species human mouse mouse mouse
# State changes 367 1153 645 144
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® Technology Platform heatmap key
for Figure 6, Figure 7, and 8. Figure 6 and 7 show the
RCR-predicted hypotheses from the four verification
d a t as e t sw h i c hw e r ep r e s e n ti nt h el i t e r a t u r em o d e l .
Figure 6 shows the predictions for many nodes in the
core Cell Cycle block, including increased E2F1, 2, and
3 activities, consistent with their published role in regu-
lating cell proliferation in lung relevant cell types
[27,28]. In addition, predictions for increased MYC
activity in the RhoA and CTNNB1 data sets are consis-
tent with the reported role of MYC in positively regulat-
ing cell proliferation in lung and lung relevant cell types
[29,30]. In addition to predictions for increased activity
of positive cell proliferation mediators in data sets
where cell proliferation was experimentally induced to
increase, RCR also predicted decreased activities of
negative regulators of proliferation. Specifically,
decreases in the transcriptional activity of RB1 and
E2F4, both known negative regulators of cell cycle pro-
gression [31,32], were predicted in multiple data sets.
Likewise, decreases in the abundance of CDKN1A or
CDKN2A, cell cycle checkpoint proteins with potent
anti-proliferative effects, were also predicted in all three
data sets where proliferation was observed increased
(Figure 6) [33,34]. One interesting prediction was that of
decreased HRAS mutated at G12V. Although HRAS
activity would be expected to increase, the HRAS G12V
mutation leads to oncogene-induced senescence [35];
therefore, this hypothesis likely reflects a transcriptional
signature of decreased senescence.
RCR-predicted hypotheses appearing within the Cell
Cycle block of literature model nodes provided verifica-
tion that the proximal mechanisms regulating cell prolif-
eration were 1) correctly present in the literature model
and 2) detectable using this computational approach.
However, equally important were the predictions for
nodes in the peripheral building blocks, which 1) iden-
tify additional mechanistic detail for the proliferative
pathways modulated and 2) can be used together with
the hypothesis predictions in the core Cell Cycle block
to assess the coverage of the literature model by all four
data sets (see “Evaluation of the Cell Proliferation Net-
work”). For the purposes of highlighting the peripheral
mechanisms involved in lung cell proliferation, hypoth-
eses within the growth factors building block were espe-
cially well represented, including predicted increases in
Figure 6 Cell cycle block hypotheses predicted in consistent directions with observed cell proliferation. The expected direction of a
prediction in the table is based on the known biological role(s) for a given hypothesis, and is shown for the core Cell Cycle building block. The
arrows above the data set names (RhoA, CTNNB1, NR3C1, and EIF4G1) denote the direction in which proliferation was observed to change in
the respective experiments.
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Page 8 of 16Figure 7 Peripheral building block hypotheses predicted in consistent directions with observed cell proliferation. The expected
direction of a prediction in the table is based on the known biological role(s) for a given hypothesis, and is shown for the peripheral building
blocks (orange and white blocks in Figure 5). The arrows above the data set names (RhoA, CTNNB1, NR3C1, and EIF4G1) denote the direction in
which proliferation was observed to change in the respective experiments.
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Page 9 of 16PDGF, FGFs 1, 2 and 7, HGF, and EGF and its receptors
(Figure 7). In particular, hypotheses for decreased FGF1
and FGF7 (also known as KGF (keratinocyte growth fac-
tor)) were predicted in the EIF4G1 data set, directionally
consistent with the experimental observation of
decreased proliferation observed in MCF10A epithelial
cells. Both FGF1 and FGF7 are critical for promoting
epithelial cell proliferation in the developing respiratory
epithelium [36,37]. Several EGF receptor complexes and
their ligands, which also play central roles in regulating
normal lung cell proliferation, were also predicted as
hypotheses in this analysis [38-40]. These hypotheses
were especially noticeable in the RhoA data set, which
used NIH3T3 cells as an experimental model. Although
NIH3T3 cells normally express low levels of EGF family
receptors and are minimally responsive to EGF, RhoA
activation has been shown to decrease EGFR endocyto-
sis, which could lead to increased levels of EGF family
responsiveness in RhoA overexpressing cells [41-44].
Hypotheses from many of the other blocks of the cell
proliferation literature model are also predicted in direc-
tions consistent with the observed direction of cell pro-
liferation in the four data sets, with nodes from the cell
interaction (FN1, SRC activity), MAPK signaling (MAPK
1/3 activity, MEK family), Hedgehog (Hedgehog family,
GLI 1/2 activity), and WNT/beta-catenin (CTNNB1
activity, WNT3A) blocks being particularly well
represented.
Despite the large number of RCR-derived hypotheses
corresponding to nodes in the Cell Proliferation Net-
work predicted in directions consistent with increased
cell proliferation, some showed a different pattern. Fig-
ure 8 shows the RCR-derived hypotheses corresponding
to nodes in the Cell Proliferation Network that were
predicted in a direction that is opposite to what we
expected based on their literature-described roles in reg-
ulating lung cell proliferation. Many of these hypotheses
are pleiotropic signaling molecules, which are involved
in other processes in addition to proliferation, and may
result from the perturbation of non-proliferative areas of
biology in the data sets examined. For example, the
“response to hypoxia” and transcriptional activity of
HIF1A (taof(HIF1a)) predictions may be more indicative
of angiogenesis than proliferation. Additionally, some of
these hypotheses may be predicted in unexpected direc-
tions due to feedback mechanisms or other forms of
regulation. Finally, these predictions may also result
from alternative activities of these signaling molecules
that have not been described in the literature, such as
the microRNA MIR192, which is still in the early stages
of research into its functions. It is important to note
that none of the hypotheses predicted in unexpected
directions are nodes in the core Cell Cycle block, an
observation that further verifies the cell proliferation lit-
erature model.
This analysis supported the model as an accurate and
comprehensive representation of cell proliferation in
the lung. Predictions for nodes in the core Cell Cycle
and Growth Factor blocks are especially robust, consis-
tent with the key role these elements play in cell pro-
liferation. The analysis also confirms the ability of RCR
to predict proliferative mechanisms based on transcrip-
tomic data from multiple, independent data sets.
Therefore, the proliferation literature model (and the
framework used to create it) appears to be very well-
suited for the evaluation of mechanisms guiding lung
cell proliferation using gene expression microarray
data sets.
Figure 8 Peripheral building block hypotheses predicted in inconsistent directions with observed cell proliferation. The expected
direction of a prediction in the table is based on the known biological role(s) for a given hypothesis, and is shown for all nodes in model.
However, because there were no hypotheses in the core Cell Cycle block that were predicted in inconsistent directions, the hypotheses shown
in this table are all from peripheral blocks (orange and white blocks in Figure 5). The arrows above the data set names (RhoA, CTNNB1, NR3C1,
and EIF4G1) denote the direction in which proliferation was observed to change in the respective experiments.
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nodes to create the integrated model
In addition to verifying the cell proliferation literature
model, RCR on the four cell proliferation data sets was
used to identify other mechanisms impacting cell prolif-
eration in the lung. The prediction of a hypothesis in a
cell proliferation data set may suggest involvement in
proliferation; however, they may also reflect other biolo-
gical processes that are affected by the experimental
perturbations in these data sets. Therefore, each of the
hypotheses predicted by RCR in these four data sets
that were not already included in the model was investi-
gated to determine its role in lung proliferation.
Hypotheses that were determined to play a role in lung
proliferation based on surveys of the literature were
then further examined to determine how they could
best be integrated into the existing literature model.
These nodes (33 in total) were then added to the model,
creating a more robust and comprehensive network of
lung proliferation. The literature model supplemented
with these data set-derived nodes is referred to in this
paper as the integrated Cell Proliferation Network, as it
takes into account not only known proliferative mechan-
isms operating in the lung from the literature, but also
additional mechanisms determined to play a role in lung
cell proliferation identified by RCR on cell proliferation
data sets. For example, the transcriptional activity of
Zbtb17 (MIZ-1), was predicted to be increased in the
C T N N B 1d a t as e t( F i g u r e6 ) .M I Z - 1i su b i q u i t o u s l y
expressed during embryonic development and has the
ability to induce growth arrest [45]. Recently, it has
been reported that the physical interaction of MIZ-1
with MYC blocks the ability of MIZ-1 to induce growth
arrest, partially through removing the ability of MIZ-1
to activate p15INK4b gene expression [46]. While
Zbtb17 is known to influence the transcriptional activity
of MYC [47], and cell proliferation in other cell types, it
does not yet have a direct literature-described role in
regulating normal lung cell proliferation. The data set-
derived nodes added to the literature model as a result
of their prediction as hypotheses in the cell proliferation
data sets are designated in Figure 6 and 7 by the “D” in
the ‘Origin’ column.
The content of the Knowledgebase (the substrate used
to build the proliferation network) used in this study is
constantly updated with the latest scientific information.
As such, the proliferation model itself is dynamic, and
has the flexibility to represent a contemporary view of
lung cell proliferation as scientific knowledge advances.
R C Rp r e d i c t i o no fag i v e nn ode using gene expression
data sets requires a minimum of four observed RNA
expression changes that are consistent with the pre-
dicted change in node activity in the Knowledgebase.
Thus, one reason that a network node may not be pre-
dicted as a hypothesis using RCR on the cell prolifera-
tion data sets is that the Knowledgebase contains too
few causal connections from the node to downstream
RNA expressions. To address this, we took advantage of
the dynamic property of the Knowledgebase to perform
targeted knowledge curation around specific nodes in
order to increase the likelihood of detecting them as
hypotheses using RCR. The extent of these curation
efforts was limited to a subset of nodes in the prolifera-
tion network, however the structural framework used in
the construction of this network allows for additional
knowledge to be incorporated in the future.
Evaluation of the Cell Proliferation Network
In order to evaluate the content of the Cell Proliferation
Network we assessed the coverage of network nodes
predicted by RCR (on the four cell proliferation data
sets) as a percentage of total network nodes that were
capable of being predicted. In all, 229 of the 848 nodes
in the Cell Proliferation Network met the minimum cri-
teria to be predicted changed by RCR (i.e. there were
four or more observed RNA expression changes consis-
tent with the predicted change contained in the Knowl-
edgebase) and are termed the “possible nodes”. Of these
229 “possible nodes”, RCR predicted changes in 102
(45%) in at least one of the four cell proliferation data
sets. Seventy one (31%) were predicted based on the
RhoA data set alone, while 31 (14%), 19 (8%) and 47
(21%) were predicted based on the CTNNB1, NR3C1,
and EIF4G1 data sets, respectively. Notably, many of the
nodes for which a prediction was not possible exert
their influences on proliferation via non-transcriptional
events, such as phosphorylation, degradation, etc., or
have limited published information regarding their influ-
ences on gene expression. As such, these nodes would
be more likely predicted to increase or decrease when
using a combination of systems biology data types (e.g.
gene expression and phosphoproteomic arrays). These
results further verify the Cell Proliferation Network, as
well as the method of using RCR to predict proliferative
mechanisms using systems biology data.
As noted in the “Network verification and expansion”
section, the ideal publicly available data set for verifying
the network would have adhered to collection of quality
control criteria including 1) non-diseased lung tissue
focus, 2) simple perturbation of primarily cell proliferation
(as opposed to other biological processes such as apopto-
sis), 3) relevant endpoint data, and 4) statistical soundness.
The data sets used for evaluating the model were chosen
because they all met criteria 2-4 detailed above, and were
also done in lung cell relevant contexts. In fact, two of
the data sets were derived from experiments done in
Westra et al. BMC Systems Biology 2011, 5:105
http://www.biomedcentral.com/1752-0509/5/105
Page 11 of 16embryonic lung, and two were done in cell types that best
approximated the biology occurring in lung cells.
The network described here is the first step in the lar-
ger objective of creating an integrated network of lung
biology. The Cell Proliferation Network portrays the sig-
naling pathways involved in normal lung cell prolifera-
tion with expanded coverage relative to existing
representations. However, it relates only a subset of the
processes involved in many complex lung diseases. For
example, lung cancer is a disease of uncontrolled cell
proliferation, but also involves response to DNA damage
and apoptosis evasion components, among others
[48,49]. Similarly, chronic lung diseases such as asthma
and COPD involve not only alterations in the prolifera-
tive aspects of cell populations, but also profound altera-
tions in the inflammatory response [50,51]. In this light,
a truly systemic evaluation of diseases such as these will
require networks that cover multiple biological pro-
cesses in a lung focused and interconnected manner. As
such, the Cell Proliferation Network is the first of sev-
eral planned networks that will be built over the coming
months to capture the known universe of biological pro-
cesses relevant for lung disease in a comprehensive, cen-
tralized, and computable structure (Additional file 2
corresponds to the entire Cell Proliferation Network in
a computable format).
Conclusions
Cell proliferation is a complex biological process with
relevance to several common lung diseases. Modern sys-
tems biology data, such as transcriptomics, are useful in
unraveling the detail embedded in complex processes
like cell proliferation, but require the appropriate tools.
The publicly available lung focused Cell Proliferation
Network described here represents the most compre-
hensive and fully referenced mechanistic representation
of the signaling pathways that regulate normal lung cell
proliferation in existence, and is compatible with analy-
sis using systems biology data. The adaptable and com-
putable structure of the network makes it a useful tool
for a wide variety of research investigators across broad
scientific disciplines.
Methods
Knowledgebase and Knowledge Assembly Models
The nodes and edges comprising the Cell Proliferation
Network were added to the model from the Selventa
Knowledgebase, a comprehensive repository containing
over 1.5 million nodes (biological concepts and entities)
and over 7.5 million edges (connections between nodes).
The Selventa Knowledgebase is derived from peer-
reviewed scientific literature as well as other public and
proprietary databases. In addition to containing a vast
collective of causal relationships derived from healthy
tissues, the Knowledgebase is particularly enriched in
disease areas such as inflammation, metabolic diseases,
cardiovascular injury, liver injury and cancer. Knowledge
Assembly Models (KAMs) are subsets of the global Sel-
venta Knowledgebase designed to facilitate reasoning
and computation (Figure 9).
The human KAM is the set of causal assertions from
human sources that has been augmented with ortholo-
gous causal assertions derived from either mouse or rat
sources, and is competent for RCR (see Reverse Causal
Reasoning (RCR): Automated Hypothesis Generation).
Similarly, the mouse KAM is the set of causal assertions
derived from mouse sources that has been augmented
with orthologous causal assertions derived from either
human or rat sources. Each KAM contains approxi-
mately 90,000 total nodes and 400,000 total edges,
incorporating information from over 35,000 distinct
citations. An example causal assertion is increased tran-
scriptional activity of EGR1 (early growth response 1)
causing an increase in the expression of CCND1 (cyclin
Figure 9 Pie charts showing the nodes (biological entities, left) and causal edges (causal relationships, right) contained in the Human
Knowledge Assembly Model (KAM). Knowledge Assembly Models are collections of nodes (biological entities) and causal edges (causal
relationships) and are used as substrates for Reverse Causal Reasoning (RCR). The number of nodes and causal edges contained in the Human
KAM for each sub-category is shown in parentheses. These pie charts are a snapshot of the Human KAM as of August 18, 2010; the KAM is
continually being expanded and refined. KAMs are also maintained for Mouse and Rat, and additional custom KAMs can also be created. Every
KAM represents a subset of the global Selventa Knowledgebase.
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citation, and the assembled collection of these causal
assertions is referred to as either the human or mouse
KAM in this paper. The Selventa Knowledgebase and
KAMs provide a framework for developing computable,
qualitative models of specific areas of biology.
When analyzing public gene expression data sets for
the construction and verification of the network, the full
h u m a nK A Mw a su s e da st h es u b s t r a t ef o rR C R ;h o w -
ever the Cell Proliferation Network itself (the nodes and
edges that make up the physical network connectivity)
reflects a subset of all the causal assertions in the
human KAM.
Reverse Causal Reasoning (RCR): Automated hypothesis
generation
Reverse causal reasoning (RCR) was used to verify and
expand the Cell Proliferation Network using cell prolif-
eration experiments with publicly available transcrip-
tomic profiling data. RCR interrogates a species-specific
KAM to identify upstream controllers of the RNA State
Changes (see Analysis of transcriptomic data sets sec-
tion) observed in the data set. These upstream control-
lers are called “hypotheses”, as they are statistically
significant potential explanations for the observed RNA
State Changes. Hypothesis generation is performed
automatically by a computer program that utilizes the
KAM to identify hypotheses that explain the input RNA
State Changes, prioritized by multiple statistical criteria.
The substrate for analysis of RNA State Changes
observed in the cell proliferation data sets is a species-
specific KAM, which is derived from the global Selventa
Knowledgebase. For the EIF4G1 data set, the human
KAM was used, while the mouse KAM was used for the
RhoA, CTNNB1, and NR3C1 data sets.
Each hypothesis is scored according to two probabilis-
tic scoring metrics, richness and concordance, which
examine distinct aspects of the probability of a hypothe-
tical cause explaining a given number of RNA State
Changes (see next section). Richness is the probability
that the number of observed RNA State Changes con-
nected to a given hypothesis could have occurred by
chance alone. Concordance is the probability that the
number of observed RNA State Changes that match the
directionality of the hypothesis (e.g., increased or
decreased kinase activity for a kinase, increased or
decreased transcriptional activity for a transcription fac-
tor, etc.) could have occurred by chance alone. A scored
hypothesis is considered to be statistically (although not
necessarily biologically) significant if it meets richness
and concordance p-value cutoffs of 0.1. Following auto-
mated hypothesis generation (which can generate hun-
dreds of hypotheses for a given data set analysis), each
scored hypothesis meeting the minimum statistical
cutoffs for richness and concordance is evaluated and
prioritized by a group of scientists based on its biologi-
cal plausibility and relevance to the experimental pertur-
bation used to generate the data. Evaluation and
prioritization was based on multiple criteria, including
the mechanistic proximity of the hypothesis to non-dis-
eased lung biology and evidence that the hypothesis is
present or has activity in normal lung or lung-related
cells. When constructing this network, each hypothesis
was collaboratively evaluated by teams of scientists from
both Philip Morris International (PMI) and Selventa.
For a more comprehensive and detailed explanation on
hypothesis scoring and evaluation, please refer to [52].
Many hypotheses identified using RCR on the cell
proliferation data sets were already represented in the
literature model; those that were not represented in the
literature model were investigated by evaluation of their
biological relevance to the lung context and whether
they are causally linked to phenotypes and processes
relevant to cell proliferation in the literature. Hypotheses
meeting the above criteria were then added to the litera-
ture model as data set-driven nodes, creating the inte-
grated network model. Thus, RCR allowed for
verification, testing, and expansion of the Cell Prolifera-
tion Network using publicly available proliferation data
sets.
Analysis of transcriptomic data sets
Four previously published cell proliferation data sets,
GSE11011 (EIF4G1), GSE5913 (RhoA), PMID15186480
(CTNNB1), and E-MEXP-861 (NR3C1), were used for the
verification and expansion of the Cell Proliferation Net-
work (Table 2). These data sets was chosen for a variety of
reasons, including 1) the relevance of the experimental per-
turbation to modulating the types of cell proliferation that
can occur in cells of the normal lung, 2) the availability of
raw gene expression data, 3) the statistical soundness of
the underlying experimental design, and 4) the availability
of appropriate cell proliferation endpoint data associated
with each transcriptomic data set. In addition, the pertur-
bations used to modulate cell proliferation in these experi-
ments covered mechanistically distinct areas of the Cell
Proliferation Network, ensuring that robust coverage of
distinct mechanistic pathways controlling lung cell prolif-
eration were reflected in the network. Data for GSE11011
and GSE5913 were downloaded from Gene Expression
Omnibus (GEO) http://www.ncbi.nlm.nih.gov/gds, while
data for E-MEXP-861 was downloaded from ArrayExpress
http://www.ebi.ac.uk/microarray-as/ae/. The data from
PMID15186480 was obtained from a link within the online
version of the paper http://jbiol.com/content/3/3/11. Raw
RNA expression data for each data set were analyzed using
the “affy” and “limma” packages of the Bioconductor suite
of microarray analysis tools available for the R statistical
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background correction and quantile normalization were
used to generate microarray expression values for the Affy-
metrix platform data sets, EIF4G1, RhoA, and CTNNB1.
Quantile normalization was applied to analysis of the GE
Codelink platform data set, NR3C1. An overall linear
model was fit to the data for all sample groups, and specific
contrasts of interest were evaluated to generate raw p-
values for each probe set on the expression array [57]. The
Benjamini-Hochberg False Discovery Rate (FDR) method
was then used to correct for multiple testing effects.
Probe sets were considered to have changed qualita-
tively in a specific comparison if an adjusted p-value of
0.05 was obtained and they had an absolute fold change
greater than 1.3. An additional expression abundance fil-
ter was applied to three of the data sets; probe set dif-
ferences were considered significant only if the average
expression intensity was above 250 in either the control
or treated group for the EIF4G1 and RhoA data sets,
and above 10 for the NR3C1 data set. No abundance
threshold was applied to the CTNNB1 data set. These
criteria were applied to optimize State Change numbers
for RCR. NetAffx version na30 feature annotation files,
available from Affymetrix http://www.Affymetrix.com,
were used for mapping of probe sets to genes. Genes
represented by multiple probe sets were considered to
have changed if at least one probe set was observed to
change. Gene expression changes that met these criteria
are called “State Changes” and have the directional qua-
lities of “increased” or “decreased”, i.e., they were upre-
gulated or downregulated, respectively in response to
the experimental perturbation. The number of State
Changes for each data set is listed in Table 2.
Additional material
Additional file 1: The Cell Proliferation Network Model nodes-
edges-evidence. this excel file contains the complete list of evidences
associated to all nodes and edges present in the Cell Proliferation
Network.
Additional file 2: The Cell Proliferation Network Model. this file
contains the Cell Proliferation Network Model in “OWL Web Ontology
Language” format.
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